[Cogitum in children’s neurology and psychiatry (experience in the practical use)].
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(7. Vyp. 2):58-66
Authors: Goryunova AV, Shevchenko YS, Goryunov AV
The authors review current data on the role of the synthetic aspartic acid analogue N-acetyaspartate (NAA) in various biochemical metabolic reactions in the CNS. Its importance as a biomarker for neuropsychiatric disorders identified using magnetic resonance spectroscopy (MRS) is noted. The authors present their own results of the use of cogitum, a synthetic analogue of NAA, in children with the effects of traumatic brain injury, mental retardation, hyperactivity disorder and in the complex therapy of schizotypal disorder. Effects of cogitum on cognitive deficit, asthenia are evaluated. The neurotrophic effect of the drug, which specifically affects cognitive and asthenic disorders in these diseases, is shown.
PMID: 31532592 [PubMed – indexed for MEDLINE]